Novel Cell-Based Therapy Promising for Alzheimer’s Disease
PHILADELPHIA — An experimental, cell-based therapy met its primary safety and secondary efficacy endpoints in a phase 2b study on...
PHILADELPHIA — An experimental, cell-based therapy met its primary safety and secondary efficacy endpoints in a phase 2b study on...